BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• 

  Deals

  Angelini inks $4.1B Catalyst buy to enter US rare disease market

  Catalyst Pharmaceuticals comes with a trio of approved drugs as Angelini Pharma expands its neuroscience offerings.

  May 7, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• 

  Layoffs

  Gilead wipes out most of Arcellx workforce

  Gilead is laying off Arcellx employees in California and Maryland, with some cuts effective this year and the remainder happening in 2027.

  May 7, 2026

   · 

  1 min read

   · 

  Angela Gabriel
• 

  FDA

  FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit

  The FDA turned away Ebvallo in January, taking issue with the design of the registrational trial. In a recent meeting, however, the agency agreed that the study could in fact support the cell therapy’s approval. The news comes a week after the departure of controversial biologics Director Vinay Prasad.

  May 7, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Job Trends

  2026 Q1 Job Market Report: Job postings picked up as quarter progressed

  Opportunities increased by the end of the first quarter, according to BioSpace data.

  May 7, 2026

   · 

  4 min read

   · 

  Angela Gabriel
• Press Releases

  Genmab Announces Financial Results for the First Quarter of 2026

  May 7, 2026

   · 

  6 min read
• Press Releases

  Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

  May 7, 2026

   · 

  4 min read
• Press Releases

  MedCognetics and AWS Bring AI-Powered Breast Cancer Screening to Underserved Communities in India

  May 7, 2026

   · 

  1 min read
• 

  Manufacturing

  FDA pilots AI-informed one-day facility inspections

  Implemented as part of a broader initiative to make more targeted and efficient use of inspection resources, the pilot program will use artificial intelligence to enable shorter, focused screenings to complement standard FDA inspections.

  May 7, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

  Completion of Lead Clinical Candidate PH-762 Dose Escalation Trial for Treatment of Skin Cancer with Favorable Safety and Pathology Data

  May 7, 2026

   · 

  8 min read